Actos Side Effects Lawsuit
May 8, 2012 – For over a year, scientists have informed of analysis results displaying that long-term use of the diabetic issues medication Actos is associated with an improved chance of kidney melanoma. In May […]
Increasing 2011 lawful activities against Takeda included a move toward class-action situations and multidistrict lawsuits. Since Aug 2011, class-action statements have been registered in the U.S. Region Legal courts in La, Celui-ci, New York, New […]
Many people who have developed kidney melanoma because of their therapy with Actos and other pioglitazone medicines have registered legal statements against Takeda Treatment, the maker of Actos, to receive settlement for healthcare costs, as […]
The US Food and Treatment Management (FDA) has announced a potential security issue with Actos (pioglitazone HCL) being related to rhabdomyolysis. A potential security issue means that the FDA has not identified that there is […]
Issues about the protection of Actos have become the focus of an Actos whistleblower judge activity. A former Takeda Treatment consultant, Dr. Sue Ge, has stepped ahead and stated that Takeda downplayed her issues regarding […]
Actos (pioglitazone hydrochloride) is a member of a type of drugs known as thiazolidinediones, which have been related to liver organ and heart issues. Actos adverse reactions include improved chance of congestive center failing (CHF), […]
Since hitting the industry in the late 90’s, doctors have recommended Actos to millions of kind 2 diabetics. Although the medication does help with diabetic issues, healthcare analysis a weblink between Actos and serious, life-threatening […]